RxDoctor Payments Data

Bhavanadhar Penta

Interventional Cardiology · New York, NYNPI 1669171781

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,625 of the $17,895 with a category attached, or 70.5%. It is spread thinly across 27 manufacturers, the largest accounting for just 17.6%. Reporting peaked in 2024 at $10,941 and has fallen 55.7% since, to $4,844 in 2025.

$17,895in general payments, 2019–2025

Across 393 payments — averaging $45.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Edwards Lifesciences$2K
  • Shockwave Medical, Inc$2K
  • Abbott$2K
  • Abiomed$1K
  • Cardiva Medical, Inc.$1K
  • plus $6K from 21 others

What the payments were for

  • Grants$1,0636%
  • Travel & lodging$4,20624%
  • Food & beverage$12,62571%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,895 in reported general payments places this provider in the 65th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York →

Other interventional cardiology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →